Research Topics

Andrea D Basso


Affiliation: Merck Research Laboratories
Country: USA


  1. Basso A, Liu M, Dai C, Gray K, Nale L, Tevar S, et al. SCH 2047069, a novel oral kinesin spindle protein inhibitor, shows single-agent antitumor activity and enhances the efficacy of chemotherapeutics. Mol Cancer Ther. 2010;9:2993-3002 pubmed publisher
    ..SCH 2047069 showed antitumor activity in a variety of preclinical models as a single agent and in combination with paclitaxel, gemcitabine, or vincristine. ..